image

The best stocks to buy since 1993

Latest issue now available

IndigoVision

April 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • IND
  • Price:
  • 369p
In the light of IndigoVision’s interims, N+1 Brewin has lifted its full year eps forecast by 20% to 25.8p and for next year by 27% to 32.4p. Results for the half year to 31 January were in line. The standout new information on what was said last month in our main write up is that net cash, helped by a £1m reduction in stock, has  ballooned to £7.2m. That is up 43% year-on-year and represents 96p per share.   Although H1 sales were down 4% year-on-year at £14.5m, they went up by 4% sequentially. But, as anticipated, it was a higher gross margin (60%) bolstered by lower overheads (down 4%) that helped Indigo deliver a record H1 pretax profit of £1.6m, up £0.2m year on year. Eps went up 19% to 15.6p. &nbs ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe